Megestrol treatment in patients with hepatocellular carcinoma.
Farinati
F
F
Gianni
S
S
De Giorgio
M
M
Fiorentini
S
S
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000737:chemistry / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D008113:Liver Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D008297:Male; D008535:Megestrol / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000032:analysis
D018931:Antineoplastic Agents, Hormonal; D000509:alpha-Fetoproteins; D008535:Megestrol